TrialExperimental dermatology2021

Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double-blind Phase Ib study.

Alex Walker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.